Perhaps, the downregulation of Rhobtb1 by Ang II may be the product of both mechanisms acting simultaneously, which may be interpreted as attempts to maintain the structural integrity (e.g., stiffness) of arterial wall and prevent aneurysm or rupture under conditions of marked hypertension. The gene discussed is RHOBTB1; the disease is aneurysm.